{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:46:40Z","timestamp":1790999200400,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.bbi.2024.03.049","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T16:24:40Z","timestamp":1711729480000},"page":"188-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies"],"prefix":"10.1016","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-0630","authenticated-orcid":false,"given":"Jonah F.","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"F\u00f6cking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Heurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subash Raj","family":"Susai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Kodosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Cornblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Mathalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie E.","family":"Bearden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin S.","family":"Cadenhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Addington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyrone D.","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clark","family":"Jeffries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S22","key":"10.1016\/j.bbi.2024.03.049_b0005","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1192\/S0007125000292581","article-title":"Assessing depression in schizophrenia: the Calgary depression scale","volume":"163","author":"Addington","year":"1993","journal-title":"Br. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.bbi.2024.03.049_b0010","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2012.09.012","article-title":"North American prodrome longitudinal study (NAPLS 2): overview and recruitment","volume":"142","author":"Addington","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.bbi.2024.03.049_b0015","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/NMD.0000000000000290","article-title":"North American prodrome longitudinal study (NAPLS 2): the prodromal symptoms","volume":"203","author":"Addington","year":"2015","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.bbi.2024.03.049_b0020","series-title":"North American prodrome longitudinal study (NAPLS 3): methods and baseline description","author":"Addington","year":"2020"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0025","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1192\/bjp.2022.179","article-title":"Relationship between polygenic risk scores and symptom dimensions of schizophrenia and schizotypy in multiplex families with schizophrenia","volume":"223","author":"Ahangari","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.bbi.2024.03.049_b0030","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/npp.2017.164","article-title":"Complement gene expression Correlates with Superior frontal cortical thickness in humans","volume":"43","author":"Allswede","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2024.03.049_b0035","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.schres.2016.12.021","article-title":"Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. results from the national FACE-SZ cohort","volume":"185","author":"Andrianarisoa","year":"2017","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0045","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/wps.21071","article-title":"Biomarkers in psychiatric disorders: status quo, impediments and facilitators","volume":"22","author":"Berk","year":"2023","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0050","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1021\/acs.jproteome.0c00536","article-title":"Importance of block randomization when designing proteomics experiments","volume":"20","author":"Burger","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbi.2024.03.049_b0060","first-page":"sbad184","article-title":"Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study","author":"Byrne","year":"2024","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41398-023-02623-y","article-title":"Prognostic models predicting transition to psychotic disorder using blood-based biomarkers: a systematic review and critical appraisal","volume":"13","author":"Byrne","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0065","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.2023.21","article-title":"Psychosocial and behavioural interventions for the negative symptoms of schizophrenia: a systematic review of efficacy meta-analyses","volume":"223","author":"Cella","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"7","key":"10.1016\/j.bbi.2024.03.049_b0070","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1038\/tp.2015.91","article-title":"Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset","volume":"5","author":"Chan","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0075","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.schres.2014.09.012","article-title":"What drives poor functioning in the at-risk mental state?","volume":"159","author":"Cotter","year":"2014","journal-title":"A Systematic Review. Schizophrenia Research."},{"issue":"12","key":"10.1016\/j.bbi.2024.03.049_b0080","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nbt.1511","article-title":"MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification","volume":"26","author":"Cox","year":"2008","journal-title":"Nat. Biotechnol."},{"issue":"43","key":"10.1016\/j.bbi.2024.03.049_b0085","doi-asserted-by":"crossref","first-page":"10363","DOI":"10.1021\/bi00107a001","article-title":"The coagulation cascade: initiation, maintenance, and regulation","volume":"30","author":"Davie","year":"1991","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.bbi.2024.03.049_b0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/HRP.0000000000000273","article-title":"Negative symptoms and functioning in youth at risk of psychosis: a systematic review and meta-analysis","volume":"28","author":"Devoe","year":"2020","journal-title":"Harv. Rev. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0095","doi-asserted-by":"crossref","first-page":"14005","DOI":"10.1038\/npjschz.2014.5","article-title":"Predictors of outcome in early-onset psychosis: a systematic review","volume":"1","author":"D\u00edaz-Caneja","year":"2015","journal-title":"NPJ Schizophr."},{"issue":"6","key":"10.1016\/j.bbi.2024.03.049_b0100","article-title":"Clinician rating scales: alcohol use scale (AUS), drug use scale (DUS), and substance abuse treatment scale (SATS)","volume":"113","author":"Drake","year":"1996","journal-title":"Outcomes Assessment in Clinical Practice."},{"key":"10.1016\/j.bbi.2024.03.049_b0105","series-title":"Inflammation in first-episode psychosis: the contribution of inflammatory biomarkers to the emergence of negative symptoms, a systematic review and meta-analysis","author":"Dunleavy","year":"2022"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/schbul\/sbx075","article-title":"Blood-based protein changes in childhood are associated with increased risk for later psychotic Disorder: evidence from a nested case-control study of the ALSPAC longitudinal birth cohort","volume":"44","author":"English","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0115","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-4838(99)00266-6","article-title":"Regulation of blood coagulation. biochimica et biophysica acta (BBA) -","volume":"1477","author":"Esmon","year":"2000","journal-title":"Protein Structure and Molecular Enzymology."},{"issue":"3","key":"10.1016\/j.bbi.2024.03.049_b0120","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.psychres.2015.05.018","article-title":"Why are help-seeking subjects at ultra-high risk for psychosis help-seeking?","volume":"228","author":"Falkenberg","year":"2015","journal-title":"Psychiatry Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1192\/bjp.2023.69","article-title":"A new era for the negative symptoms of schizophrenia","volume":"223","author":"Fernandez-Egea","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0130","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41380-018-0306-z","article-title":"Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stress","volume":"26","author":"F\u00f6cking","year":"2021","journal-title":"Mol Psychiatry."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0135","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1001\/jamapsychiatry.2013.269","article-title":"The psychosis high-risk state: a comprehensive state-of-the-art review","volume":"70","author":"Fusar-Poli","year":"2013","journal-title":"JAMA Psychiat."},{"issue":"4","key":"10.1016\/j.bbi.2024.03.049_b0140","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/schbul\/sbu170","article-title":"Treatments of negative symptoms in schizophrenia: meta-analysis of 168 randomized placebo-controlled trials","volume":"41","author":"Fusar-Poli","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.bbi.2024.03.049_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.bbi.2018.11.315","article-title":"Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis","volume":"76","author":"Goldsmith","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2024.03.049_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.878199","article-title":"Endogenous regulators of hemostasis and thrombosis","volume":"9","author":"Grover","year":"2022","journal-title":"Frontiers in Cardiovascular Medicine."},{"issue":"3","key":"10.1016\/j.bbi.2024.03.049_b0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(95)71666-8","article-title":"Global assessment of functioning: a modified scale","volume":"36","author":"Hall","year":"1995","journal-title":"Psychosomatics"},{"key":"10.1016\/j.bbi.2024.03.049_b0160","first-page":"Q8","article-title":"Package \u2018rms\u2019","volume":"229","author":"Harrell","year":"2017","journal-title":"Vanderbilt University."},{"key":"10.1016\/j.bbi.2024.03.049_b0165","doi-asserted-by":"crossref","unstructured":"Harrell Jr FE. Regression Modeling Strategies With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. 2nd ed. Springer Cham; 2015. https:\/\/doi.org\/10.1007\/978-3-319-19425-7.","DOI":"10.1007\/978-3-319-19425-7"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2012.03.025","article-title":"Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation","volume":"140","author":"Harvey","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2024.03.049_b0175","doi-asserted-by":"crossref","unstructured":"Healy C, Byrne J, Raj Suasi S, et al. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms. Brain, Behavior, and Immunity. Published online January 12, 2024. doi:10.1016\/j.bbi.2023.12.018.","DOI":"10.1016\/j.bbi.2023.12.018"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0180","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41380-021-01197-9","article-title":"Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis","volume":"27","author":"Heurich","year":"2022","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.2023.57","article-title":"Treating negative symptoms of schizophrenia: current approaches and future perspectives","volume":"223","author":"Howes","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.bbi.2024.03.049_b0190","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0272-7358(01)00103-9","article-title":"The continuity of psychotic experiences in the general population","volume":"21","author":"Johns","year":"2001","journal-title":"Clin. Psychol. Rev."},{"issue":"10","key":"10.1016\/j.bbi.2024.03.049_b0195","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","article-title":"Association of Serum Interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study","volume":"71","author":"Khandaker","year":"2014","journal-title":"JAMA Psychiat."},{"issue":"3","key":"10.1016\/j.bbi.2024.03.049_b0200","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/acps.12030","article-title":"Psychopathological long-term outcome of schizophrenia\u2013a review","volume":"127","author":"Lang","year":"2013","journal-title":"Acta Psychiatr. Scand."},{"issue":"10","key":"10.1016\/j.bbi.2024.03.049_b0205","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","article-title":"Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors","volume":"174","author":"Leucht","year":"2017","journal-title":"Am. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.bbi.2024.03.049_b0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1192\/bjp.bp.116.197103","article-title":"Psychological and psychosocial interventions for negative symptoms in psychosis: systematic review and meta-analysis","volume":"210","author":"Lutgens","year":"2017","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0215","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/eip.12217","article-title":"Duration of active psychosis and first-episode psychosis negative symptoms","volume":"11","author":"Lyne","year":"2017","journal-title":"Early Interv. Psychiatry"},{"issue":"4","key":"10.1016\/j.bbi.2024.03.049_b0220","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/eip.12501","article-title":"Negative symptoms of psychosis: a life course approach and implications for prevention and treatment","volume":"12","author":"Lyne","year":"2018","journal-title":"Early Interv. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0225","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/wps.20809","article-title":"The clinical characterization of the patient with primary psychosis aimed at personalization of management","volume":"20","author":"Maj","year":"2021","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0230","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/wps.20385","article-title":"The current conceptualization of negative symptoms in schizophrenia","volume":"16","author":"Marder","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.bbi.2024.03.049_b0235","series-title":"Structured interview for psychosis-risk syndromes","author":"McGlashan","year":"2001"},{"key":"10.1016\/j.bbi.2024.03.049_b0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system Part I - Molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2024.03.049_b0250","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2017.01.047","article-title":"The course of negative symptoms in first-episode schizophrenia and its predictors: a prospective two-year follow-up study","volume":"189","author":"Mezquida","year":"2017","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.bbi.2024.03.049_b0255","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/0968-0004(92)90004-S","article-title":"Common subunits of cytokine receptors and the functional redundancy of cytokines","volume":"17","author":"Miyajima","year":"1992","journal-title":"Trends Biochem. Sci"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0260","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2020.2459","article-title":"Development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence","volume":"78","author":"Mongan","year":"2021","journal-title":"JAMA Psychiat."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0265","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.psychres.2014.07.019","article-title":"Relative contributions of negative symptoms, insight, and coping strategies to quality of life in stable schizophrenia","volume":"220","author":"Montemagni","year":"2014","journal-title":"Psychiatry Res."},{"issue":"Suppl 1","key":"10.1016\/j.bbi.2024.03.049_b0270","article-title":"Cytokine pleiotropy and redundancy: a view from the receptor","volume":"12","author":"Nicola","year":"1994","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/schbul\/sbu099","article-title":"Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project","volume":"41","author":"Perkins","year":"2015","journal-title":"Schizophr Bull."},{"key":"10.1016\/j.bbi.2024.03.049_b0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2021.02.008","article-title":"Childhood inflammatory markers and risks for psychosis and depression at age 24: examination of temporality and specificity of association in a population-based prospective birth cohort","volume":"230","author":"Perry","year":"2021","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bbi.2024.03.049_b0285","first-page":"3","article-title":"Linear mixed-effects models: basic concepts and examples. mixed-effects models in S and S-plus","author":"Pinheiro","year":"2000","journal-title":"Published Online"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0290","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.psychres.2012.02.018","article-title":"Negative symptoms in individuals at clinical high risk of psychosis","volume":"196","author":"Piskulic","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2024.03.049_b0295","unstructured":"R Core Team R. R: A language and environment for statistical computing. Published online 2013."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0300","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2012.01.015","article-title":"Negative symptoms have greater impact on functioning than positive symptoms in schizophrenia: analysis of CATIE data","volume":"137","author":"Rabinowitz","year":"2012","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.schres.2013.07.014","article-title":"Association of prominent positive and prominent negative symptoms and functional health, well-being, healthcare-related quality of life and family burden: a CATIE analysis","volume":"150","author":"Rabinowitz","year":"2013","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0310","doi-asserted-by":"crossref","first-page":"e1001380","DOI":"10.1371\/journal.pmed.1001380","article-title":"Prognosis Research strategy (PROGRESS) 2: prognostic factor Research","volume":"10","author":"Riley","year":"2013","journal-title":"PLoS Med."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0315","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1192\/bjp.2022.203","article-title":"Negative symptoms in children and adolescents with early-onset psychosis and at clinical high-risk for psychosis: systematic review and meta-analysis","volume":"223","author":"Salazar de Pablo","year":"2023","journal-title":"Br. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0320","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","article-title":"The complement system","volume":"343","author":"Sarma","year":"2011","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0325","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.schres.2016.06.017","article-title":"The relationship between experiential deficits of negative symptoms and subjective quality of life in schizophrenia","volume":"176","author":"Savill","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bst0320021","article-title":"Proteases of the complement system","volume":"32","author":"Sim","year":"2004","journal-title":"Biochem. Soc. Trans."},{"issue":"4","key":"10.1016\/j.bbi.2024.03.049_b0335","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3109\/10409238.2015.1050550","article-title":"How it all starts: initiation of the clotting cascade","volume":"50","author":"Smith","year":"2015","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bbi.2024.03.049_b0340","first-page":"1","article-title":"Psychotic experiences in the general population, a review; definition, risk factors, outcomes and interventions","author":"Staines","year":"2022","journal-title":"Psychol. Med.. Published Online"},{"key":"10.1016\/j.bbi.2024.03.049_b0345","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbi.2022.03.013","article-title":"Machine learning based prediction and the influence of complement\u2013coagulation pathway proteins on clinical outcome: results from the NEURAPRO trial","volume":"103","author":"Susai","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2024.03.049_b0350","doi-asserted-by":"crossref","DOI":"10.1093\/schizbullopen\/sgad014","article-title":"Negative symptom trajectories in individuals at clinical high risk for psychosis: differences based on deficit syndrome","author":"Tran","year":"2023","journal-title":"Persistence, and Transition Status. Schizophrenia Bulletin Open."},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0355","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.schres.2014.07.021","article-title":"Persistent negative symptoms after first episode schizophrenia: a 2-year follow-up study","volume":"158","author":"\u00dc\u00e7ok","year":"2014","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0360","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1017\/S0033291708003814","article-title":"A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness\u2013persistence\u2013impairment model of psychotic disorder","volume":"39","author":"van Os","year":"2009","journal-title":"Psychol. Med."},{"key":"10.1016\/j.bbi.2024.03.049_b0365","doi-asserted-by":"crossref","unstructured":"Woods SW, Walsh BC, Powers AR, McGlashan TH. Reliability, Validity, Epidemiology, and Cultural Variation of theStructured Interview for Psychosis-Risk Syndromes (SIPS) and theScale of Psychosis-Risk Symptoms (SOPS). In: Li H, Shapiro DI, Seidman LJ, eds. Handbook of Attenuated Psychosis Syndrome Across Cultures: International Perspectives on Early Identification and Intervention. Springer International Publishing; 2019:85-113. doi:10.1007\/978-3-030-17336-4_5.","DOI":"10.1007\/978-3-030-17336-4_5"},{"issue":"2","key":"10.1016\/j.bbi.2024.03.049_b0370","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/wps.21079","article-title":"Biomarkers for clinical use in psychiatry: where are we and will we ever get there?","volume":"22","author":"Yatham","year":"2023","journal-title":"World Psychiatry"},{"issue":"1","key":"10.1016\/j.bbi.2024.03.049_b0375","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-022-02305-1","article-title":"Serum complement proteins rather than inflammatory factors is effective in predicting psychosis in individuals at clinical high risk","volume":"13","author":"Zhang","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.bbi.2024.03.049_b0380","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat. Rev. Immunol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124003301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889159124003301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T00:36:37Z","timestamp":1729298197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889159124003301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":74,"alternative-id":["S0889159124003301"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.03.049","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studies","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}